Treatment of multiple myeloma, Blood, vol.103, issue.1, pp.20-32, 2004. ,
DOI : 10.1182/blood-2003-04-1045
URL : https://hal.archives-ouvertes.fr/inserm-00368414
Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma, British Journal of Haematology, vol.96, issue.2, pp.665-674, 2004. ,
DOI : 10.1046/j.1365-2141.1998.01075.x
Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells, J Immunol, vol.163, pp.514-524, 1999. ,
Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells, Clin Cancer Res, vol.5, pp.705-709, 1999. ,
T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells, Proceedings of the National Academy of Sciences, vol.99, issue.20, pp.13009-13013, 2002. ,
DOI : 10.1073/pnas.202491499
Activated Marrow-Infiltrating Lymphocytes Effectively Target Plasma Cells and Their Clonogenic Precursors, Cancer Research, vol.65, issue.5, pp.2026-2034, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-3337
Graftversus-myeloma effect: proof of principle, Blood, vol.87, pp.1196-1198, 1996. ,
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma, Blood, vol.102, issue.9, pp.3447-3454, 2003. ,
DOI : 10.1182/blood-2002-09-2955
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma, Blood, vol.104, issue.10, pp.3361-3363, 2004. ,
DOI : 10.1182/blood-2004-05-2031
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells, Haematologica, vol.88, pp.1139-1149, 2003. ,
Dendritic Cell-based Immunotherapy in Multiple Myeloma, Leukemia & Lymphoma, vol.100, issue.12, pp.2031-2038, 2003. ,
DOI : 10.1016/S0145-2126(02)00002-4
Current status of therapeutic vaccines for non-Hodgkin??s lymphoma, Current Opinion in Oncology, vol.17, issue.5, pp.432-440, 2005. ,
DOI : 10.1097/01.cco.0000174040.52427.83
Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma Tumor antigens recognized by T lymphocytes, Eur J Immunol. Int J Clin Lab Res, vol.26, issue.27, pp.2671-2679, 1996. ,
Tumor-specific shared antigenic peptides recognized by human T cells, Immunological Reviews, vol.164, issue.1, pp.51-64, 1999. ,
DOI : 10.1002/(SICI)1521-4141(199902)29:02<602::AID-IMMU602>3.0.CO;2-Y
Cancer/testis antigens, gametogenesis and cancer, Nature Reviews Cancer, vol.62, issue.8, pp.615-625, 2005. ,
DOI : 10.1111/j.1432-1033.1996.t01-1-00827.x
The cancer/testis genes: review, standardization, and commentary The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies, Cancer Immun. Clin Cancer Res, vol.4, issue.10, pp.6544-6550, 2004. ,
Identification of a Novel Human Cancer/Testis Antigen, KM-HN-1, Recognized by Cellular and Humoral Immune Responses, Clinical Cancer Research, vol.10, issue.18, pp.6047-6057, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-0475
Identification of cancer/testis-antigen genes by massively parallel signature sequencing, Moingeon, J. Tartaglia, P. van der Bruggen, P. G. Coulie, and T. Boon, pp.7940-7945, 2005. ,
DOI : 10.1073/pnas.0502583102
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, Journal of Experimental Medicine, vol.179, issue.3, pp.921-930, 1994. ,
DOI : 10.1084/jem.179.3.921
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens, The Journal of Experimental Medicine, vol.154, issue.8, pp.1349-1354, 1998. ,
DOI : 10.1097/00008390-199612000-00003
Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular Carcinoma, Clinical Cancer Research, vol.10, issue.13, pp.4332-4341, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-0181
CD8+T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burden, Blood, vol.106, issue.13, pp.4217-4224, 2005. ,
DOI : 10.1182/blood-2005-02-0563
Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation, Blood, vol.102, issue.2, pp.592-600, 2003. ,
DOI : 10.1182/blood-2002-10-3161
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses, Oncogene. Blood, vol.24, issue.105, pp.2461-2473, 2005. ,
The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation, Blood, vol.106, issue.1, pp.167-174, 2005. ,
DOI : 10.1182/blood-2004-12-4931
Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma, Blood, vol.83, pp.3654-3663, 1994. ,
A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma, Blood, vol.91, pp.4727-4737, 1998. ,
Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors, Leukemia, vol.14, issue.1, pp.188-197, 2000. ,
DOI : 10.1038/sj.leu.2401632
Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts, Blood, vol.100, pp.1113-1122, 2002. ,
Cluster analysis and display of genome-wide expression patterns, Proceedings of the National Academy of Sciences, vol.95, issue.25, pp.14863-14868, 1998. ,
DOI : 10.1073/pnas.95.25.14863
A gene atlas of the mouse and human protein-encoding transcriptomes, Proceedings of the National Academy of Sciences, vol.101, issue.16, pp.6062-6067, 2004. ,
DOI : 10.1073/pnas.0400782101
Expression of cancer/testis (CT) CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease, Genes encoding tumor-specific antigens are expressed in human myeloma cells, pp.3148-3157, 1999. ,
Tumour-associated antigens in multiple myeloma, Br J Haematol, vol.120, pp.3-9, 2003. ,
Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies, Blood, vol.101, issue.3, pp.955-960, 2003. ,
DOI : 10.1182/blood-2002-06-1930
SSX Cancer Testis Antigens are Expressed in Most Multiple Myeloma Patients, Journal of Immunotherapy, vol.28, issue.6, pp.564-575, 2005. ,
DOI : 10.1097/01.cji.0000175685.36239.e5
Simultaneous Humoral and Cellular Immune Response against Cancer???Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2???binding Peptide Epitopes, The Journal of Experimental Medicine, vol.157, issue.2, pp.265-270, 1998. ,
DOI : 10.1097/00008390-199612000-00003
Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients, Cancer Res, vol.60, pp.4499-4506, 2000. ,
Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma, Blood, vol.100, issue.3, pp.961-965, 2002. ,
DOI : 10.1182/blood-2002-02-0408
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance, New England Journal of Medicine, vol.346, issue.8, pp.564-569, 2002. ,
DOI : 10.1056/NEJMoa01133202
Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy, The Journal of Experimental Medicine, vol.147, issue.11, pp.1753-1757, 2003. ,
DOI : 10.1016/S0952-7915(02)00317-5
DNA hypermethylation in tumorigenesis: epigenetics joins genetics, Trends in Genetics, vol.16, issue.4, pp.168-174, 2000. ,
DOI : 10.1016/S0168-9525(99)01971-X
Promoter Demethylation and Histone Acetylation Mediate Gene Expression of MAGE-A1, -A2, -A3, and -A12 in Human Cancer Cells, Molecular Cancer Research, vol.4, issue.5, pp.339-349, 2006. ,
DOI : 10.1158/1541-7786.MCR-05-0229
Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non-Small Cell Lung Cancer, Clinical Cancer Research, vol.11, issue.22, pp.8055-8062, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-1203
Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance, International Journal of Oncology, vol.28, pp.1089-1098, 2006. ,
DOI : 10.3892/ijo.28.5.1089
The clinical significance ofMAGEA3 expression in pancreatic cancer, International Journal of Cancer, vol.55, issue.9, pp.2269-2275, 2006. ,
DOI : 10.1002/ijc.21656
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes, Science, vol.298, issue.5594, pp.850-854, 2002. ,
DOI : 10.1126/science.1076514
T cells, The Journal of Experimental Medicine, vol.163, issue.7, pp.907-912, 2005. ,
DOI : 10.4049/jimmunol.173.12.7209
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer, Nature Medicine, vol.104, issue.11, pp.1230-1237, 2005. ,
DOI : 10.1046/j.1365-2141.1998.00930.x
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. Blood. Oct 5 Epub ahead of print Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor, Specific Cellular Immune Responses in the Bone Marrow Microenvironment of Multiple Myeloma Patients. In ASH, pp.356-59, 2006. ,
Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma, Blood, vol.105, issue.5, pp.2132-2134, 2005. ,
DOI : 10.1182/blood-2004-01-0366
Identification of a new HLA-A2???restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma, Experimental Hematology, vol.34, issue.4, pp.486-496, 2006. ,
DOI : 10.1016/j.exphem.2006.01.008
URL : https://hal.archives-ouvertes.fr/inserm-00131759